893
Participants
Start Date
September 7, 2017
Primary Completion Date
August 24, 2020
Study Completion Date
December 20, 2020
OncAlert
A noninvasive point of care salivary rinse test performed as 1) a one-time test for patients presenting with suspicion of OPMD and scheduled for biopsy and 2) a multi-administered test for patients presenting with suspicious lesions not scheduled for biopsy.
Specialty Physician Associates, Bethlehem
University of Maryland, Baltimore
Piedmont Ear, Nose and Throat Associates, Winston-Salem
Duke Head and Neck Surgery & Communication Services, Durham
Eastern Carolina University School of Dental Medicine, Greenville
Medical University of South Carolina, Charleston
University of Miami Health Systems, Miami
ENT of South Florida Plantation, Plantation
Asclepes Research, Weeki Wachee
ENT of South Florida Port St. Lucie, Port Saint Lucie
University of Tennessee, Memphis
Heartland Medical Research, Clive
Chicago ENT, Chicago
UMKC School of Dentistry, Kansas City
Berkson Medical, LLC, Mansfield
Fort Worth ENT, Fort Worth
Chrysalis Clinical Research, St. George
Tower ENT, based at Cedars Sinai Medical Center, Los Angeles
Dr. Joel Epstein, Beverly Hills
Biosolutions Clinical Research Center, La Mesa
Loma Linda School of Dentistry, Loma Linda
Sacramento ENT, Roseville
Sacramento ENT, Sacramento
UConn Dental Medicine, Farmington
Tufts University, Boston
Boston University Dental School, Boston
Collaborators (1)
Pearl Pathways
UNKNOWN
Vigilant Biosciences, Inc.
INDUSTRY